API
< Back to all clusters
[HEALTH] · South Korea · 2 sources

started · updated

JW Pharmaceutical discusses iron management at Korean Society of Obstetrics and Gynecology

JW Pharmaceutical held a luncheon symposium during the 112th Korean Society of Obstetrics and Gynecology academic conference and the 31st Seoul International Symposium. The event focused on the clinical value of Ferinject, a high-dose intravenous iron injection.

Professor Oh-young Kim from Catholic University of Korea Yeouido St. Mary’s Hospital presented on effective iron management during pregnancy and postpartum. Kim highlighted that anemia and iron deficiency during pregnancy can impact maternal outcomes as well as fetal brain and neurodevelopment. The presentation emphasized the necessity of evaluating iron status using ferritin levels alongside hemoglobin to ensure early diagnosis.

Ferinject was presented as a clinical option for patients requiring rapid iron replenishment, such as those with increased demands before or after childbirth or those experiencing bleeding. Additionally, the company noted that under current health insurance coverage, patients may be exempt from out-of-pocket costs for the injection if administered during hospitalization for childbirth, covering both natural and cesarean deliveries.

Entities

Ferinject · JW Pharmaceutical · Korean Society of Obstetrics and Gynecology · Oh-young Kim · Yeouido St. Mary’s Hospital